Association Study of the Complement Component C4 Gene in Tardive Dyskinesia-Reference-Cited by-同舟云学术

Association Study of the Complement Component C4 Gene in Tardive Dyskinesia

Published:2019-11-26 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Zai Clement C.,Tiwari Arun K.,Zai Gwyneth C.,Freeman Natalie,Pouget Jennie G.,Greco James,Tampakeras Maria,Shaikh Sajid A.,Herbert Deanna,Emmerson Heather,Cheema Sheraz Y.,Braganza Nicole,Müller Daniel J.,Voineskos Aristotle N.,Remington Gary,Kennedy James L.

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference40 articles.

1. Genomewide association study of movement-related adverse antipsychotic effects;Aberg;Biol. Psychiatry,2010

2. Altered IL-2, IL-6 and IL-8 serum levels in schizophrenia patients with tardive dyskinesia;An;Schizophr. Res.,2015

3. Complement activation at the motor end-plates in amyotrophic lateral sclerosis;Bahia El Idrissi;J. Neuroinflammation,2016

4. White matter abnormalities in schizophrenia patients with tardive dyskinesia: a diffusion tensor image study;Bai;Schizophr. Res.,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the complement component C4 gene with schizophrenia subphenotypes;Schizophrenia Research;2024-09

2. Analysis of schizophrenia‐associated genetic markers in the HLA region as risk factors for tardive dyskinesia;Human Psychopharmacology: Clinical and Experimental;2024-04-27

3. Association study of the complement component C4 gene and suicide risk in schizophrenia;Schizophrenia;2024-02-10

4. Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments;Pharmaceutics;2024-02-07

5. Evaluation of Serum Complement Levels and Factors Affecting Treatment Resistance in Patients with Schizophrenia;Psychiatry and Clinical Psychopharmacology;2023-06-20